Results 251 to 260 of about 346,758 (357)
ABSTRACT Background Buccinator myomucosal flaps (BMFs) have been proposed as a reconstructive solution for defects of the tongue and oral floor; however, their harvest requires preservation of the facial artery and vein. This study aimed to evaluate the oncologic safety of this approach compared with free fasciocutaneous flaps (FFF).
Luigi Angelo Vaira +24 more
wiley +1 more source
Combined transcranial and endoscopic endonasal approach for anterior skull base meningiomas: approach and reconstruction strategies. [PDF]
Whipple-Bones S +4 more
europepmc +1 more source
Quality of Life After Surgical Treatment of Head and Neck Paragangliomas
ABSTRACT Background Head and neck paragangliomas (HNPGLs) are rare neuroendocrine tumors and often arise in the head and neck. Due to their localization, the tumor and its surgical treatment pose a risk for cranial nerve impairments. Few studies have focused on the health‐related quality of life (HRQOL) in patients with HNPGLs and their relation to ...
Christina Sauter +5 more
wiley +1 more source
A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene. [PDF]
Lin SZ, Sun XY, Tan YY, Qi YF, Jiang K.
europepmc +1 more source
ABSTRACT Background The microvascular bone free flap (MBFF) is the preferred reconstruction after mandibular resection as it facilitates secondary dental rehabilitation. Methods In this multicenter study, patients were included if treated between January 2017 and January 2022 for head and neck cancer with MBFF reconstruction.
Lise‐Marie Roussel +11 more
wiley +1 more source
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling. [PDF]
Iudici M +24 more
europepmc +1 more source
ABSTRACT Objective To compare functional and oncologic outcomes in elderly (≥ 70 years) and nonelderly (< 70 years) patients after transoral robotic surgery (TORS). Methods A retrospective chart review was conducted on 114 patients who underwent TORS for head and neck squamous cell carcinoma between 2012 and 2022.
Erim Pamuk +6 more
wiley +1 more source

